Probiotic Impact on Cognitive Performance, and Metabolic Outcomes in Overweight Young Adults With Impaired Glucose Regulation

NARecruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

August 15, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

August 20, 2026

Conditions
Impaired Glucose RegulationImpaired Glucose Tolerance (Prediabetes)Prediabetes (Insulin Resistance, Impaired Glucose Tolerance)Overweight (BMI > 25)Cognitive DysfunctionNeurovascular Coupling Mechanism and Cognitive Function
Interventions
DIETARY_SUPPLEMENT

Lab4p Probiotic Consortium

"The investigational product in this study is Lab4P, a patented multi-strain probiotic consortium formulated as a food supplement and supplied in capsule form. Each daily dose contains a total of 5 × 10¹⁰ CFU of live bacteria, comprising five strains: Lactobacillus acidophilus CUL60 and CUL21, Lactobacillus plantarum CUL66, Bifidobacterium bifidum CUL20, and Bifidobacterium animalis subsp. lactis CUL34. In addition to probiotics, each capsule also contains three micronutrients at 100-200% of the recommended daily intake: Vitamin D (10 µg; 200%), Vitamin C (80 mg; 100%), and Zinc (10 mg; 100%).~Lab4P is a marketed, human-approved product manufactured by Cultech Ltd. (Port Talbot, UK) and is classified as a food supplement, available for purchase without prescription. Both the active product and placebo will be identically packaged to maintain blinding."

OTHER

Placebo

Placebo capsules are composed of microcrystalline cellulose, and are identical in appearance to the test product.

Trial Locations (1)

LS1 3HE

RECRUITING

Leeds Beckett University, Leeds

All Listed Sponsors
collaborator

Cultech Ltd, Port Talbot, UK

UNKNOWN

lead

Leeds Beckett University

OTHER

NCT07073781 - Probiotic Impact on Cognitive Performance, and Metabolic Outcomes in Overweight Young Adults With Impaired Glucose Regulation | Biotech Hunter | Biotech Hunter